Incannex Healthcare (IXHL) Net Income towards Common Stockholders (2022 - 2026)

Incannex Healthcare (IXHL) has reported Net Income towards Common Stockholders for 5 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 2.14% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY) and the FY2025 annual result came in at -$46.9 million, down 154.0% from the prior year.
• Net Income towards Common Stockholders rose to -$3.9 million in Q1 2026 per IXHL's latest filing, from -$6.5 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for IXHL reached as high as -$726000.0 in Q3 2023 and fell as low as -$31.6 million in Q2 2025.
• A 5-year average of -$6.6 million and a median of -$5.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders slumped 646.56% — and 2025, when it soared 34.21%.
• Year by year, Net Income towards Common Stockholders stood at -$2.9 million in 2022, then tumbled by 79.61% to -$5.2 million in 2023, then declined by 12.46% to -$5.9 million in 2024, then retreated by 10.64% to -$6.5 million in 2025, then surged by 40.45% to -$3.9 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$3.9 million, -$6.5 million, and -$6.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.